| Phillip Steinkraus, | |
|
92 Broadway, Suite 102, Greenlawn, NY 11740-1328 | |
| (631) 262-7855 | |
| (631) 262-7854 |
| Full Name | Phillip Steinkraus |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 9 Years |
| Location | 92 Broadway, Greenlawn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003280645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 039690 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Physical Occupational And Speech Therapy Pllc | 1254553639 | 323 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
| Provider Name | Professional Orthopedic And Sports Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356453633 PECOS PAC ID: 7911989827 Enrollment ID: O20040922000120 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
| Provider Name | Sherrie Glasser Physical Therapist Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912099540 PECOS PAC ID: 0648169276 Enrollment ID: O20090601000014 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
| Provider Name | Metro Physical Occupational And Speech Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356742365 PECOS PAC ID: 1254553639 Enrollment ID: O20141120000039 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
| Provider Name | Professional Occupational & Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205296902 PECOS PAC ID: 3779873401 Enrollment ID: O20160608000715 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phillip Steinkraus, 2142 Utopia Pkwy, Whitestone, NY 11357-4142 Ph: (718) 819-6805 | Phillip Steinkraus, 92 Broadway, Suite 102, Greenlawn, NY 11740-1328 Ph: (631) 262-7855 |
News Archive
Obesity is taking a hefty toll on the health of children and young adults, leaving more Americans facing the burden of a lifetime of diabetes care and management.
Pharmaceutical QA/QC, oil and gas, chemical, water and environmental, food safety and contract laboratories can now offer always-on mobile connectivity to their Laboratory Information Management System (LIMS) software, providing access to data and insights for decision-making wherever and whenever they need it.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
› Verified 9 days ago
Catherine Sturniolo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 92 Broadway, Suite 102, Greenlawn, NY 11740 Phone: 631-262-7855 | |
Mrs. Diane C. Amantia, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Fenwick St, Greenlawn, NY 11740 Phone: 631-757-4063 Fax: 631-757-4063 | |
Professional Occupational & Physical Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 92 Broadway Ste 102, Greenlawn, NY 11740 Phone: 631-262-7855 Fax: 631-262-7854 | |
Comfort Care Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Ruwaner Ct, Greenlawn, NY 11740 Phone: 631-742-1390 Fax: 631-754-0907 | |
Mr. Christopher A Junker, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 761a Pulaski Rd, Greenlawn, NY 11740 Phone: 631-261-6680 Fax: 631-261-6684 | |
Progressive Physical Therapy & Rehabilitation Physical Therapist Medicare: Medicare Enrolled Practice Location: 266 East Pulaski Rd, Suite 3, Greenlawn, NY 11740 Phone: 631-673-4600 Fax: 631-673-4621 |